Home » Topics » Regulatory

Regulatory
RSS

First worldwide approval for Exjade in U.S.

Nov. 3, 2005

No Comments

Noxafil approved in E.U. for invasive fungal infections

Oct. 28, 2005

No Comments

Ebixa receives European approval for moderate Alzheimer's disease

Oct. 14, 2005

No Comments

Japan approves fluvoxamine maleate for social anxiety disorder

Oct. 14, 2005

No Comments

Remicade approved in E.U. for moderate to severe plaque psoriasis

Oct. 7, 2005

No Comments

European approval for Vasovist for magnetic resonance angiography

Oct. 5, 2005

No Comments

GSK's Zefix approved in Japan for HBV-associated cirrhosis

Sep. 26, 2005

No Comments

Remicade now approved in U.S. for ulcerative colitis

Sep. 20, 2005

No Comments

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

No Comments

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

First worldwide approval for Exjade in U.S.

Noxafil approved in E.U. for invasive fungal infections

Ebixa receives European approval for moderate Alzheimer's disease

Japan approves fluvoxamine maleate for social anxiety disorder

Remicade approved in E.U. for moderate to severe plaque psoriasis

European approval for Vasovist for magnetic resonance angiography

GSK's Zefix approved in Japan for HBV-associated cirrhosis

Remicade now approved in U.S. for ulcerative colitis

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Actoplus Met approved for type 2 diabetes

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Regulatory RSS

Regulatory
RSS